المؤلفون: Yu-Shih Lin, Chang Geng-He, Wu Ching-Yuan, Li-Hsin Shu, Cheng-Ming Hsu, Yao-Hsu Yang, Yu-Heng Wu, Ming-Shao Tsai, Yu-Huei Wu, Yu-Ching Cheng, Reming-Albert Yeh, Hung-Te Liu, Rou-Chen Shen

المصدر: Biomedicine & Pharmacotherapy, Vol 142, Iss, Pp 112011-(2021)
Biomedicine & Pharmacotherapy

مصطلحات موضوعية: Conformational change, Lineage (genetic), medicine.drug_class, RM1-950, Spike protein, medicine.disease_cause, Monoclonal antibody, Antiviral Agents, Antioxidants, Catechin, Article, RBD, receptor binding domain, Theaflavin 3-gallate (Pubchem CID: 136825044), T3G, Theaflavin 3-gallate, Epsilon variant, Gallic Acid, Drug Discovery, medicine, Biflavonoids, Humans, Protein Interaction Domains and Motifs, GU, glycyrrhiza uralensis Fisch. ex DC, COVID-19, coronavirus disease 2019, Pharmacology, Infectivity, Medicine, East Asian Traditional, Mutation, biology, ACE2, angiotensin converting enzyme 2, SARS-CoV-2, The severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, HEK 293 cells, Wild type, COVID-19, General Medicine, Theaflavin (Pubchem CID: 135403798), Virology, Antibodies, Neutralizing, Beta variant, HEK293 Cells, Spike Glycoprotein, Coronavirus, biology.protein, Angiotensin-Converting Enzyme 2, (+)-Catechin (Pubchem CID: 9064), GB-2, Therapeutics. Pharmacology, Antibody, Protein Binding

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b8b5718aedf022bf1c4712f6d0b9d96
http://www.sciencedirect.com/science/article/pii/S0753332221007940

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.